Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase III, Multi-centre, Randomized Study to Compare the Efficacy and Safety of Levonadifloxacin (IV and Oral) With Linezolid (IV and Oral) in Acute Bacterial Skin and Skin Structure Infections (ABSSSI)

NCT03405064 is registered in ClinicalTrials.gov with Wockhardt as lead sponsor.

NCT NCT03405064
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03405064 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase III, Multi-centre, Randomized Study to Compare the Efficacy and Safety of Levonadifloxacin (IV and Oral) With Linezolid (IV and Oral) in Acute Bacterial Skin and Skin Structure Infections (ABSSSI)
Lead sponsor
Wockhardt
Phase
Phase 3
Overall status
Completed
Start date
August 25, 2017
Completion date
November 30, 2018
Enrollment
501 (actual)
Sites
32

Conditions

As the registry lists them; a condition with its own page is linked.

acute bacterial skin and skin structure infections